不同糖尿病亚组与全因、癌症及心血管相关死亡率的关联
本研究基于NHANES III数据纳入712名成人,中位随访12.71年,评估5个糖尿病亚组(SAID、SIDD、SIRD、MOD、MARD)的全因、心血管及癌症死亡风险。SAID和SIDD亚组视网膜病变风险高于MARD亚组。
要点
- 全因死亡和癌症死亡风险在各糖尿病亚组间无显著差异。
- SAID和SIDD亚组视网膜病变风险高于MARD亚组,肾病风险无差异。
核心结论
- 在糖尿病亚组中,MARD亚组心血管相关死亡风险高于MOD亚组,全因和癌症死亡率相似。
- SAID和SIDD亚组视网膜病变风险高于MARD亚组,肾病风险无差异。
研究设计与样本
- 基于NHANES III数据集的队列研究,纳入年龄≥20岁的712名成人。
- 中位随访12.71年(范围0.25-18.08年),评估5个糖尿病亚组的全因和病因特异性死亡风险。
主要发现
- 5个亚组(SAID、SIDD、SIRD、MOD、MARD)死亡人数分别为50、75、64、7、18,心血管相关死亡人数分别为29、30、26、2、11。
- 肾病OR在各亚组间无统计学显著性。
临床怎么用
- 对MARD亚组糖尿病患者应加强心血管风险评估与管理。
- SAID和SIDD亚组患者需注意视网膜病变筛查。
局限性
- 研究基于NHANES III数据集,样本量712人,部分亚组事件数较少。
- 随访时间范围较宽,可能存在残余混杂。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Numerous studies have shown that cardiovascular disease (CVD) represents the most important cause of mortality among people with diabetes mellitus (DM). However, no studies have evaluated the risk of CVD-related mortality among different DM subgroups. OBJECTIVE: We aimed to examine all-cause, CVD-related, and cancer-related mortality for different DM subgroups. DESIGN, SETTING, PATIENTS, AND INTERVENTIONS: We included participants (age ≥ 20 years) from the National Health and Nutrition Examination Survey III (NHANES III) data set. We evaluated the risks of all-cause and cause-specific (CVD and cancer) mortality among 5 previously defined diabetes subgroups: severe autoimmune diabetes (SAID), severe insulin-deficient diabetes (SIDD), severe insulin-resistant diabetes (SIRD), mild obesity-related diabetes (MOD), and mild age-related diabetes (MARD). PRIMARY OUTCOME MEASURE: The hazard ratios (HRs) for all-cause and cause-specific (CVD and cancer) mortality were measured for each of the 5 DM subgroups. We also evaluated the odds ratios (ORs) for retinopathy and nephropathy in each subgroup. RESULTS: A total of 712 adults were enrolled and the median follow-up time was 12.71 years (range, 0.25-18.08 years). The number of deaths in the 5 subgroups (SAID, SIDD, SIRD, MOD, and MARD) were 50, 75, 64, 7, and 18, respectively, and the number of CVD-related deaths in the 5 subgroups was 29, 30, 26, 2, and 11, respectively. Compared to the MOD subgroup, the adjusted HRs and 95% CIs of CVD-related mortality for the SAID, SIDD, SIRD, and MARD subgroups were 3.23 (95% CI, 0.77-13.61), 2.87 (95% CI, 0.68-12.06), 2.23 (95% CI, 0.53-9.50), and 4.75 (95% CI, 1.05-21.59), respectively (the HR for the MARD subgroup had a P value of .04). In addition, compared to the MARD subgroup, the adjusted ORs and 95% CIs for retinopathy in the SAID and SIDD groups were 2.38 (95% CI, 1.13-5.01, P = .02) and 3.34 (95% CI, 1.17-6.88, P = .001), respectively. The ORs for nephropathy were nonsignificant. CONCLUSIONS: Our study of patients from the NHANES III data set indicated that among the different DM subgroups, the MARD subgroup tended to have a higher CVD-related mortality than the MOD subgroup. The all-cause and cancer-related mortality rates were similar across the different diabetes subgroups. In addition, compared to the MARD subgroup, the SAID and SIDD subgroups had a higher retinopathy risk, but there was no difference in nephropathy among the subgroups.
引用
- Li PF, Chen WL. Are the Different Diabetes Subgroups Correlated With All-Cause, Cancer-Related, and Cardiovascular-Related Mortality? J Clin Endocrinol Metab. 2020. PMID: 32893854. doi:10.1210/clinem/dgaa628
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。